The Nature and Clinical Significance of Atypical Mononuclear Cells in Infectious Mononucleosis Caused by the

Olga S Fedyanina1,2, Anna E Filippova1, Olga I Demina3,4

  • 1Dmitry Rogachev National Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.

Insights

Atypical mononuclear cells (AM), primarily CD8+ T cells, are key indicators in Epstein-Barr virus (EBV)-associated infectious mononucleosis (IM). Lower CD8+ AM percentages correlate with slower recovery from primary EBV infections in children.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Atypical mononuclear cells (AM) are characteristic of Epstein-Barr virus (EBV)-associated infectious mononucleosis (IM).
  • Understanding the phenotype and quantity of AM is crucial for diagnosing and monitoring IM, especially in children.

Purpose of the Study:

  • To investigate the number and CD expression of atypical mononuclear cells in children with IM.
  • To differentiate AM populations in primary EBV infection, EBV reactivation, and other viral infections.
  • To explore the relationship between AM characteristics and recovery rates in pediatric IM.

Main Methods:

  • Utilized anti-CD antibody microarray for leukocyte analysis in 110 children with IM.
  • Panned leukocytes based on surface markers before morphology examination.
  • Quantified AM populations and analyzed CD expression (CD8+, CD19+).

Main Results:

  • AM population in IM predominantly comprised CD8+ T cells, with a minor fraction of CD19+ B cells.
  • Higher AM counts were observed in primary EBV infections compared to EBV reactivation or other viral causes.
  • Children with delayed recovery from primary EBV-associated IM showed significantly lower percentages of CD8+ AM.

Conclusions:

  • CD8+ T cells are the primary component of atypical mononuclear cells in pediatric IM.
  • AM quantification and CD8+ T cell percentage can serve as biomarkers for IM diagnosis and prognosis.
  • Lower CD8+ AM levels may indicate a prolonged recovery period in children with primary EBV infection.